However, PDT-LUAD#119 lung tumoroids harboring EML4-ALK v3 and TP53 mutations were as sensitive to ALK TKI as NCI-H3122 cells with EML4-ALK v1 and TP53 mutations in the present study. This evidence concerns the gene ALK and medical procedure.